Most Recent
Rugby Australia is considering an insolvent trading cross-claim against the directors of the Melbourne Rebels, in a suit by the failed team which was cut from next year’s Super Rugby Pacific competition.
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
Holding Redlich has lost a veteran environment partner with extensive experience representing government clients and his team to Maddocks, marking the firm's second lateral loss this week.
Logistics giant Qube has won a $40 million cut to amounts owed to Martinus Rail in a dispute over construction of the Moorebank terminal project in Sydney's west.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
White & Case has snagged a partner from Maddocks with more than 25 years of experience in corporate real estate to assist the firm on global transactions and restructurings.
The French association representing wine producers from Champagne has discontinued its lawsuit against an Australian retailer after it agreed to only use seed extract from the Champagne region of France.
In a win for ASIC, the Federal Court has found that non-bank lender Firstmac Limited breached the design and distribution obligations, introduced in 2021, by marketing a managed investment scheme that could be unsuitable for customers’ financial needs.
Industrial technology company Delta Building Automation has appealed a $1.5 million penalty for attempting to rig a bid for construction work on the National Gallery of Australia, a penalty five times the amount it claimed it should face.
The United Firefighters Union has lost an appeal of two Fair Work Commission decisions, with the Full Federal Court finding that a commissioner did not err in deciding the matter at a later time.